CONGRESS REGISTRATION IS NOW OPEN.

THE 2026 27TH ANNUAL CONGRESS FEATURES:

New half-day specialty summits on the afternoon of Tuesday 10/13

Over 50 concurrent mini summits and 15 plenary session presentations

The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs

The Industry-only Compliance Best Practices Think Tank hosted by PCF

A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives

Numerous professional networking opportunities

DOJ KEYNOTE ADDRESS

Brenna Jenny, JD, MPH

Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US DOJ; Former Principal Deputy General Counsel & Chief Legal Officer, Centers for Medicare & Medicaid Services, US HHS, Washington, DC

FEATURED ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

Peter Brensilver, JD, MPH

Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY

Terra Buckley, JD

Chief Compliance & Ethics Officer, Bristol Myers Squibb; Former CCO, LivaNova, Summit, NJ

Briana Cabrera, MS, CFE

Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL

Regina Cavaliere, JD

Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY

Kevin Espinoza, MBA

Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA

Yelena Ferreira, JD

Assistant GC & Head of Compliance, Pharmacosmos; Former Senior Director, Associate General Counsel, Pacira, Morristown, NJ

Lindsey LaMoria Gavin

Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL

Kate Godfrey, JD, CCEP

Senior Vice President, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA

Abe Kassis, MBA, PhD

Global Head Compliance & Legal Operations, Bausch + Lomb; Former Global Compliance Director, Takeda, New York, NY

Jeffrey Kawalek, MBA

Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY

Cheryl Lee, MBA, CHC

Head of Compliance, Cycle; Former VP, ESG Strategy & Execution, BMS; Former VP, Head of Compliance Worldwide Markets, Celgene, New York, NY

Peter Lee, JD, LLM

Chief Compliance Officer, Kura Oncology; Former CCO, Mirati Therapeutics; Former CCO, Heron Therapeutics, San Diego, CA

Melissa T. Lozner, JD

Senior VP, CCO, Regeneron; Former Chief Compliance & Ethics Officer, Rafael Holdings; Former VP, Head of Ethics, Risk & Compliance, Novartis, Tarrytown, NY

Joan Podleski, CCEP, CHPC, CHRC, CHC

VP & CPO, Children’s Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX

Ariadna Quesada, MSJ

VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain

R. Brett Short, CHC, CHPC, CHRC

CCO & CPO, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY

Ronald Strauss, CIPM

Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA

Betsy Wade, MPH, CHC, CHPC, CAN

Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY

Kelly Willenberg, MBA, DBA, CHC, CHRC

Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

Amy Wilson, MBA, MSJ

VP & CCO, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA

Stacy E. Yeung, JD

VP & GC, SELLAS; Former Assistant General Counsel, Arena Pharmaceuticals; Former Deputy General Counsel, DBV Technologies, New York, NY

FORMER GOVERNMENT OFFICIALS

Corey R. Amundson, JD

Partner, King & Spalding; Former Head, Public Integrity Section, US DOJ; Former Acting US Attorney, Middle District of Louisiana, Washington, DC

Jennifer L. Bragg, JD

Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC

Hui Chen, JD

Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI

Deborah A. Curtis, JD

Partner, Arnold & Porter; Former Deputy GC, CIA; Former Deputy Chief, Counterespionage, US DOJ, Washington, DC

John Delacourt, JD

Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC

Greg Demske, JD

Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC

Sarah A. Franklin, JD

Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC

Gejaa T. Gobena, JD

Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

John Kelly, JD

Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

Barbara A. Leaf, JD

Senior International Policy Advisor, Arnold & Porter; Former Special Assistant to the President; Former US Ambassador, UAE, Washington, DC

Michael L. Shaw, JD

Global Head of Compliance, Privacy and Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, OIG US HHS, Princeton, NJ

Jane H. Yoon, JD

Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney’s Office for the District of New Jersey, New York, NY

OTHER FEATURED FACULTY

Eliza L. Andonova, JD

Partner, Global Regulatory, Hogan Lovells, Washington, DC

Samantha Barrett Badlam, JD

Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

Yogesh Bahl, MBA

Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY

Craig B. Bleifer, JD

Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk, New York, NY

Eric Bolesh

Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Jennifer Ceglinski, JD, CFE

Manager, Forensic & Integrity Services, EY, Charlotte, NC

Benjamin Correa, JD

Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC

Zachary Coseglia, JD

Co-Founder, Culture. Data. Ethics; Former VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA

Layla Covington, JD

Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL

Clarissa Crain

Managing Director, Deloitte, Phoenixville, PA

Meena Datta, JD

Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

Mahnu V. Davar, MA, JD

Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

Stefanie A. Doebler, JD

Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

Kip Ebel, MBA

Principal, Forensic & Integrity Services, EY, New York, NY

Aurelie Ercoli, LLM, PhD

Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC

Ronnie H. Feldman

Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL

David Fisher, MS

President, TDI Solutions; Former VP & General Manager, Cyber Innovations, Battelle, Washington, DC

Sara K. Frank, JD

Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

Gary F. Giampetruzzi, JD

Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY

Neeraj Gupta, MBA

President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

Kris Hall, JD, CIPP/CIPM

Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME

Kristin M. Hicks, JD

Partner, Arnold & Porter, Washington, DC

Emily F. Hodge, JD

Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

Casey J. Horton, CFE

Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL

Mark A. Jensen, JD

Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC

Erin Brown Jones, MA, JD

Partner, Latham & Watkins, Washington, DC

Olivia Krzeminski, JD

Director of Compliance & Legal Research, G&M Health, Somerset, NJ

Jeffrey Low, RPh, MHA

Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ

Robert Melillo, JD

Co-founder and Managing Director, G&M Health, Cocoa Beach, FL

Brook Mishler, RN, MSN

Global Director of Compliance Solutions, Life Sciences, Case IQ; Former Compliance Officer for the Americas, Cordis, Ontario, Canada

Katherine C. Norris, MPA

Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI

Daniel O’Connor

Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

Saraswatha Lalitha Putcha

Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

Nikki Reeves, JD

Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Russell Rose, JD

Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

Jeffrey Scott, JD

Of Counsel, Life Sciences, DLA Piper; Former Lead Compliance Counsel, Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA

Paul Silver

Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA

Shannon Walker

Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada

Robert A. Wells, JD

Shareholder, Baker Donelson, Baltimore, MD

Kelly Willenberg, MBA, DBA, CHC

Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

Cobun Zweifel-Keegan, JD, CIPP/US

Managing Director, IAPP; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC

THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.